Short term tolvaptan increases water intake and effectively decreases urinary calcium oxalate, calcium phosphate, and uric acid supersaturations

PURPOSE: Many patients cannot effectively increase water intake and urine volume to prevent urinary stones. Tolvaptan, a V2 receptor antagonist, blocks water reabsorption in the collecting duct and should reduce urinary supersaturation (SS) of stone forming solutes, but this has never been proven. M...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Urol
Huvudupphovsmän: Cheungpasitporn, Wisit, Erickson, Stephen B., Rule, Andrew D., Enders, Felicity, Lieske, John C.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4870116/
https://ncbi.nlm.nih.gov/pubmed/26598423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2015.11.027
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk